Clinical trialNCT06275360RecruitingPhase 2Interventional

Repositioning Immunotherapy in VetArans With Lung Cancer

SponsorVA Office of Research and DevelopmentEnrollment25Non-Small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a multicenter Phase II single arm trial to assess the safety and efficacy of chemotherapy and immunotherapy followed by radiotherapy in patients with unresectable Stage III NSCLC.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Nithya Ramnath, MD
VA Ann Arbor Healthcare System, Ann Arbor, MI
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Va Connecticut Healthcare System West Haven Campus, West Haven, Ct
West Haven, Connecticut, United States
Recruiting
Va Central Office, Washington, Dc
Washington D.C., District of Columbia, United States
Recruiting
Richard L. Roudebush Va Medical Center, Indianapolis, in
Indianapolis, Indiana, United States
Recruiting
Va Ann Arbor Healthcare System, Ann Arbor, Mi
Ann Arbor, Michigan, United States
Michael D GreenNithya Ramnath, MD
Recruiting
Omaha Va Nebraska-Western Iowa Health Care System, Omaha, Ne
Omaha, Nebraska, United States
Recruiting
Michael E. Debakey Va Medical Center, Houston, Tx
Houston, Texas, United States
Recruiting
Richmond Va Medical Center, Richmond, Va
Richmond, Virginia, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Nivolumab →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Mar 2024
Primary completion: 28 Feb 2027
Completion: 31 Mar 2030
Last update posted: 2 Mar 2026
Registered enrollment: 25
Registry id: NCT06275360

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.